university « Science and Enterprise

Real World Evidence Shown to Emulate Some Clinical Trials

By Alan, on April 26th, 2023%

A study of insurance claims records matching the design of randomized clinical trials shows claims data can in some cases resemble clinical trial results to make causal inferences. . . . → Read More: Real World Evidence Shown to Emulate Some Clinical Trials

Biotech Partners on Synthetic Proteins to Protect Crops

By Alan, on April 24th, 2023%

A developer of synthetic antibody-like proteins for protecting crops is collaborating with a global agricultural chemical company on sustainable biologic insect controls. . . . → Read More: Biotech Partners on Synthetic Proteins to Protect Crops

Trial Shows Plant-Based Drug Helps Reduce Vaping

By Alan, on April 20th, 2023%

First results of a clinical trial show a drug derived from plants to aid in smoking cessation helps cut the use of e-cigarettes among non-smokers of burning tobacco. . . . → Read More: Trial Shows Plant-Based Drug Helps Reduce Vaping

Biotech, Undersea Researchers Partner on Carbon Capture Bacteria

By Alan, on April 19th, 2023%

A microbiome biotechnology company and an undersea research group are studying microorganisms that thrive in and consume intense carbon dioxide. . . . → Read More: Biotech, Undersea Researchers Partner on Carbon Capture Bacteria

Cancer Cell Therapy Biotech Launches, Raises $10M

By Alan, on April 11th, 2023%

A start-up company with a process for harvesting large quantities of cells that infiltrate and kill solid tumors is raising $10 million in seed venture funds. . . . → Read More: Cancer Cell Therapy Biotech Launches, Raises $10M

Investor Backing Nanotech Drug Discovery Advances

By Alan, on April 4th, 2023%

A life science venture investor is funding further development of a lower-cost molecular-level drug discovery process using nanoscale synthetic DNA strands. . . . → Read More: Investor Backing Nanotech Drug Discovery Advances

Self-Applied Patch Shown Feasible for Vaccine Delivery

By Alan, on March 31st, 2023%

A clinical trial shows a microneedle patch device for vaccine delivery applied by participants to their own arms works as well in the skin as when administered by clinicians. . . . → Read More: Self-Applied Patch Shown Feasible for Vaccine Delivery

Industry, Academic Labs Detailing ALS Treatment Actions

By Alan, on March 27th, 2023%

Researchers from a developer of neurodegenerative disease therapies and university medical center are investigating the precise workings of a promising ALS treatment. . . . → Read More: Industry, Academic Labs Detailing ALS Treatment Actions

Screening Device Company Kicks-Off Type 1 Diabetes Network

By Alan, on March 24th, 2023%

A developer of a blood-testing device that screens for kidney disease risks is the first company to join a network to advance new technology for type 1 diabetes. . . . → Read More: Screening Device Company Kicks-Off Type 1 Diabetes Network

Start-Up Licenses Protein Therapy Tech, Raises $50M

By Alan, on March 22nd, 2023%

A new company making antibodies that degrade disease-causing proteins on and outside cell surfaces is raising $50 million in its first venture funding round. . . . → Read More: Start-Up Licenses Protein Therapy Tech, Raises $50M

Subscribe for email alerts

Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Like us on Facebook

Specials

Guest Posts

Please share Science & Enterprise